USMJ Now Eligible For Adult Use-Marijuana Cultivation License In New York.
March 15 2022 - 10:15AM
InvestorsHub NewsWire
Dallas, TX --
March 15, 2022 -- InvestorsHub NewsWire -- North American
Cannabis Holdings, Inc. (USOTC:
USMJ) today announced the company has confirmed its eligibility
to apply for the new adult-use marijuana cultivation license
recently passed into law in the State of New
York.
“The governor of
New York on [February 22nd] signed a bill to provide
provisional marijuana cultivator and processor licenses for
existing hemp businesses that take certain steps to promote equity
in the emerging industry.” – Marijuana
Moment
“The Conditional Adult-Use Cultivator
License is available only to cultivators who, as of December 31,
2021, held a license to grow cannabinoid hemp and has grown and
harvested hemp in two of the past four years.” - Harter
Secrest & Emery LLP
USMJ has a subsidiary that has been
growing hemp for CBD for the past four years. The subsidiary
last week received an invitation from the New York Office of
Cannabis Management (OCM) to apply for the provisional adult-use
cannabis license.
“New York’s new law, making hemp growers
eligible for adult-use marijuana cultivation licenses, is a
fortunate turn of events and a real potential game changer for
USMJ,” said Steven Rash, CEO of
USMJ.
USMJ plans to promptly submit its
application.
USMJ is
founded on the core belief that cannabis makes people's lives
better. Cannabis can fight disease, improve wellness and do so in
an environmentally sustainable manner. North American Cannabis
Holdings is dedicated to finding the best possible applications for
cannabis to serve consumers. The Company operates USMJ.com and is
dedicated to Ongoing Cannabis Consumer Product Development that it
can incubate into Future
Spin-offs.
Visit the
company’s ecommerce site now and bookmark the site to watch for
more coming announcements and updates:
www.USMJ.com
Contact:
USMJ
Steven Rash
info@aciconglomerated.com
+1 (800)
861-1350
Disclaimer/Safe
Harbor: This news
release contains forward-looking statements within the meaning of
the Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that Alkame will achieve significant sales, the failure
to meet schedule or performance requirements of the Company's
contracts, the Company's liquidity position, the Company's ability
to obtain new contracts, the emergence of competitors with greater
financial resources and the impact of competitive pricing. In the
light of these uncertainties, the forward-looking events referred
to in this release might not occur. These statements have not been
evaluated by the Food and Drug Administration. These products are
not intended to diagnose, treat, cure, or prevent any
disease.
North American Cannabis (CE) (USOTC:USMJ)
Historical Stock Chart
From Aug 2024 to Sep 2024
North American Cannabis (CE) (USOTC:USMJ)
Historical Stock Chart
From Sep 2023 to Sep 2024